← back to search

Jan G. Hengstler

League Against Cancer · DE
Area of research
Hepatology · Cancer Research
Research interest
Research interests include Liver physiology and pathology, Carcinogens and Genotoxicity Assessment, Liver Disease Diagnosis and Treatment, and Drug Transport and Resistance Mechanisms.
h-index
93
citations
33,736
works
1,067
NIH funding
primary concept
email

Recent publications

Gut-to-bile transfer of microbially amidated minor bile acids in patients with hepatopancreatobiliary disorders.
2026cited by 2position: contributordoi
Targeting the ER stress sensor IRE1 protects the liver from fibrosis through the downregulation of the proteostasis factor P4HB/PDIA1.
2026cited by 1position: contributordoi
Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety.
2026cited by 1position: contributordoi
Selective genetic inactivation of Caspase 8 in hepatocytes ameliorates progression of MASH following Jnk deficiency.
2026cited by 1position: contributordoi
Free Fatty acid-induced disruption of hepatic vitamin D metabolism impairs bone homeostasis in an in vitro 3D human liver-bone model.
2026cited by 0position: contributordoi
Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease.
2025cited by 17position: contributordoi
Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitors
Journal of Hepatology 2025cited by 10position: middledoi
A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development
Nature Communications 2025cited by 9position: middledoi
Cannabidiol in Foods and Food Supplements: Evaluation of Health Risks and Health Claims.
2025cited by 8position: contributordoi
Regulation of KIF23 by miR-107 controls replicative tumor cell fitness in mouse and human hepatocellular carcinoma.
2025cited by 8position: contributordoi
Intestinal blood vessel-associated macrophages and gut-vascular barrier dysfunction in cirrhosis
Gut 2025cited by 8position: middledoi
A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development.
2025cited by 7position: contributordoi
Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitors.
2025cited by 5position: contributordoi
Design of optimal concentrations for in vitro cytotoxicity experiments.
2025cited by 4position: contributordoi
Characterization of children with early onset pediatric multiple sclerosis
European Journal of Paediatric Neurology 2025cited by 4position: middledoi
Characterization of children with early onset pediatric multiple sclerosis.
2025cited by 3position: contributordoi
The association between hair cortisol and burnout is moderated by age, psychosocial, and immunological markers.
2025cited by 3position: contributordoi
Keap1 Deletion Rescues Cell Death Associated With Gpx4 Loss in Hepatocytes During Acute Liver Injury.
2025cited by 2position: contributordoi
The long way from raw data to NAM-based information: Overview on data layers and processing steps.
2025cited by 2position: contributordoi
Exceptional Uptake, Limited Protein Expression: Liver Macrophages Lost in Translation of Synthetic mRNA.
2025cited by 2position: contributordoi
Intestinal blood vessel-associated macrophages and gut-vascular barrier dysfunction in cirrhosis.
2025cited by 2position: contributordoi
Bats, bugs, and babies: why stringent guidelines are needed for cause-and-effect interpretation in epidemiological studies.
2025cited by 1position: contributordoi
Fluoride intake during pregnancy: calculation of realistic exposure scenarios for individual risk assessment.
2025cited by 1position: contributordoi
Changes of cognitive functions and proinflammatory cytokines across the lifespan in latent <i>Toxoplasma gondii</i> infection.
2025cited by 1position: contributordoi
Improved identification of human hepatotoxic potential by summary variables of gene expression.
2025cited by 1position: contributordoi
Comment to "The beneficial effect of combination therapy with sulfasalazine and valsartan in the treatment of ulcerative colitis [EXCLI Journal 2021;20:236-247]".
2025cited by 0position: contributordoi
Developments in tattoo and tattoo removal toxicology.
2025cited by 0position: contributordoi
Critical discussion of recently published claims of a causal relationship between bat decline and infant mortality.
2025cited by 0position: contributordoi
Differential Protective Roles of c-Jun N-terminal Kinase-2 in Nonparenchymal Liver Cells and Hepatocytes During Cholestasis.
2025cited by 0position: contributordoi
Follow-up of GSTM1, GSTT1, and NAT2 genotyped patients with knee or hip replacement.
2025cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 47 papers (2020–2026)Marcus Schmidt · Universitäts Frauenklinik36 papers (2012–2023)Jörg Rahnenführer · TU Dortmund University35 papers (2019–2026)Jörg Reinders · TU Dortmund University29 papers (2019–2025)Jörg Rahnenführer · TU Dortmund University24 papers (2012–2023)Marcel Leist · Austrian Institute of Technology21 papers (2019–2025) · 21 papers (2020–2023)Karolina Edlund · TU Dortmund University20 papers (2012–2023) · 18 papers (2019–2025)Cristina Cadenas · TU Dortmund University18 papers (2021–2023)Walburgis Brenner · Johannes Gutenberg University Mainz17 papers (2021–2023)Katrin Madjar · Roche (Switzerland)16 papers (2021–2023)Sibylle Loibl · Breast Center15 papers (2021–2023) · 15 papers (2021–2023) · 15 papers (2021–2023)Hans-Christian Kolberg · Radex Heraklith Industriebeteiligungs (Germany)15 papers (2021–2023)Bahriye Aktas · Universität Trier15 papers (2021–2023)Rosemarie Marchan · TU Dortmund University14 papers (2012–2023) · 14 papers (2014–2022)Cristina Cadenas · TU Dortmund University12 papers (2012–2023)